<DOC>
	<DOCNO>NCT01373476</DOCNO>
	<brief_summary>Objectives study : To preliminarily evaluate efficacy safety Qideng Mingmu Capsule treatment patient diabetic retinopathy ( deficiency Qi-Yin syndrome , blood stasis syndrome ) , discuss appropriate dose period treatment .</brief_summary>
	<brief_title>Multicentre , Randomized , Controlled Trial Qideng Mingmu Capsule The Treatment Diabetic Retinopathy</brief_title>
	<detailed_description>The efficacy Qideng Mingmu capsule nourish qi-yin promote blood circulation . It use patient diabetic retinopathy differentiate deficiency Qi-Yin syndrome blood stasis syndrome traditional Chinese medicine ( TCM ) .The manifestation diabetic retinopathy ( DR ) mainly include dim dry eye , shortness breathe , fundus hemorrhage , etc.The experimental research indicate Qideng Mingmu capsule could improve GK rat ' quality life , reduce vascular endothelial growth factor ( VEGF ) level vitreous GK rat inhibit expression protein kinase C ( PKC ) , therefore capillary protective agent retinal impairment GK rat.The toxicology test prove clinical dosage Qideng Mingmu capsule safe.Both acute long-term toxicity test show toxicity .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Diagnosed nonproliferative diabetic retinopathy ( NPDR ) ，differentiated deficiency QiYin syndrome blood stasis syndrome traditional Chinese medicine ( TCM ) . bestcorrected ETDRS visual acuity study eye≥15 letter , 0.16 ( 20/125 ) decimal point method . Age 30 70 year old . Able willing give inform consent Keep level blood sugar steady last three month randomization , meanwhile glucose lower therapy could predict without change study . Eligible patient moderate severe diabetic retinopathy primarily , mild control within 15 % . All procedure participance study voluntarily , signature Informed Consent Form ( ICF ) acceptance treatment accord GCP guideline . Patients ineffective blood sugar control ( HbAlc &gt; 9 % ) without usage fundamental antidiabetic drug biguanides , sulfonylurea ( SUs ) , insulin thiazolidinediones ( TZDs ) . Patients intraocular surgery like retina photocoagulation within 6 month ; appropriate laser photocoagulation currently , condition two quadrant extensive nonperfusion area . Patients ophthalmological combined disease like glaucoma , cataract effect check eyeground deeply , nondiabetic retinopathy , uveitis , retinal detachment , diseases optic nerve , high myopia eyeground pathological change , etc . Patients severe cardiovascular disease , functional disorder liver kidney , diseases haematopoietic system ( bone marrow hypoplasia , leucopenia , anemia , etc . ) , severely abnormal electrocardiogram ( ECG ) , ALT &gt; 2 *ULN , Cr &gt; 1.5*ULN psychopaths.Patients diabetic nephropathy ( DN ) stage azotemia uremia . Pregnant woman try conceive lactation ; patient allergic constitution . Patients participate clinical trial recent one month . Patients use drug treatment diabetic retinopathy ( calcium dobesilate , Difrarel , capsule Xueshuantong , ginkgo biloba extract , Qiming granula , etc . ) past two week . Patients SBP &gt; 160mmHg DBP﹥100mmHg .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Traditional Chinese medicine</keyword>
	<keyword>Diabetic Eye Problems</keyword>
	<keyword>Retinal Disorders</keyword>
</DOC>